SBFM
HEALTHCARESunshine Biopharma Inc
$1.08+0.03 (+2.86%)PRE
Live · NASDAQ · May 8, Close
AI Insight
What's Moving SBFM Today?
No stock-specific AI insight has been generated for SBFM yet. Check back soon — insights are generated from recent news analysis.
52-Week Range
$0.95$2.43
$1.08
Fundamentals
Market Cap$5M
P/E Ratio—
EPS$-1.44
Dividend Yield—
Dividend / Share—
ROE-0.3%
Profit Margin-0.2%
Debt / Equity—
Trading
Volume34K
Avg Volume (10D)—
Shares Outstanding4.9M
SBFM News
12 articles- Sunshine Biopharma Reports Fiscal 2025 Revenue of $36.3 Million, a 4.1% Increase Over Prior YearYahoo Finance·Apr 6, 2026
- Sunshine Biopharma Scores a Major Regulatory Win to Market Domperidone in Canada (NASDAQ: SBFM)Yahoo Finance·Oct 28, 2025
- Sunshine Biopharma Gains FDA-Equivalent Clearance in Canada for Domperidone to Treat Cancer-related NauseaYahoo Finance·Oct 28, 2025
- Sunshine Biopharma Launches STD, Acne and Lyme Disease Therapy DoxycyclineYahoo Finance·Oct 20, 2025
- Sunshine Biopharma Launches Cholesterol Fighting Medicine PravastatinYahoo Finance·Oct 16, 2025
- Sunshine Biopharma is Proving That Riding Momentum is an Effective Strategy (NASDAQ:SBFM)Yahoo Finance·Oct 14, 2025
- Sunshine Biopharma Proves Microcap Ambition Can Deliver Large-Cap Level Execution (NASDAQ: SBFM)Yahoo Finance·Oct 14, 2025
- Sunshine Biopharma Allocates $5 Million for Investment in Bitcoin as Strategic Reserve Asset to Enhance Treasury ResilienceYahoo Finance·Oct 14, 2025
- Sunshine Biopharma and University of Arizona Develop a Potent New Series of Protease Inhibitors for Treatment of SARS Coronavirus InfectionsYahoo Finance·Oct 9, 2025
- Sunshine Biopharma Launches NIOPEG(R) Into $10 Billion Biologics MarketYahoo Finance·Jul 2, 2025
- Sunshine Biopharma Launches Generic Gabapentin for Neuropathic Pain in the Canadian Segment of the Global $1.92 Billion MarketYahoo Finance·Jun 11, 2025
- Sunshine Biopharma Reports 2025 First Quarter Results, Revenues Up 18% Over Same Period Last YearYahoo Finance·May 15, 2025
All 12 articles loaded
Price Data
Open$0.00
Previous Close$1.05
Day High$0.00
Day Low$0.00
52 Week High$2.43
52 Week Low$0.95
52-Week Range
$0.95$2.43
$1.08
Fundamentals
Market Cap$5M
P/E Ratio—
EPS$-1.44
Dividend Yield—
Dividend / Share—
ROE-0.3%
Profit Margin-0.2%
Debt / Equity—
Trading
Volume34K
Avg Volume (10D)—
Shares Outstanding4.9M
About Sunshine Biopharma Inc
Sunshine Biopharma, Inc., a pharmaceutical company, focuses on the development of anticancer drugs. The company is headquartered in Pointe-Claire, Canada.
HEALTHCAREDRUG MANUFACTURERS - SPECIALTY & GENERIC
Company Details
Security TypeStock
ExchangeNASDAQ
CurrencyUSD
Round Lot—
SICDRUG MANUFACTURERS - SPECIALTY & GENERIC
CIK—
Composite FIGI—
Share Class FIGI—